MeSH Review:
Health Expenditures
- Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion. Robertson, E.E., Rankin, G.O. Pharmacol. Ther. (2006)
- Overview: epilepsy surgery in developing countries. Wieser, H.G., Silfvenius, H. Epilepsia (2000)
- Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen. Krahn, M.D., Coombs, A., Levy, I.G. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. (1999)
- Redistributional consequences of community rating. Goldman, D.P., Leibowitz, A., Buchanan, J.L., Keesey, J. Health services research. (1997)
- Risk adjustment of Medicare capitation payments using the CMS-HCC model. Pope, G.C., Kautter, J., Ellis, R.P., Ash, A.S., Ayanian, J.Z., Lezzoni, L.I., Ingber, M.J., Levy, J.M., Robst, J. Health care financing review. (2004)
- Out-of-pocket payments for health care in Croatia: implications for equity. Mastilica, M., Bozikov, J. Croat. Med. J. (1999)
- Cost savings from alternative treatments for tuberculosis. Barnum, H.N. Social science & medicine (1982) (1986)
- Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care. Burd, L., Klug, M.G., Coumbe, M.J., Kerbeshian, J. J. Child Neurol. (2003)
- Health and health expenditures in adjusting and non-adjusting countries. van der Gaag, J., Barham, T. Social science & medicine (1982) (1998)
- Eliminating fixed costs: Part II--A pathway to reduced health expenditures. Weil, T.P. Managed care interface. (2002)
- Informal payment for health care: Evidence from Hungary. Gaal, P., Evetovits, T., McKee, M. Health policy (Amsterdam, Netherlands) (2006)
- Epidemiology and health economics of COPD across Europe: a critical analysis. Nowak, D., Berger, K., Lippert, B., Kilgert, K., Caeser, M., Sandtmann, R. Treatments in respiratory medicine. (2005)